| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yang Liu, Yongkai Chen, Carly R Duffy, Ariel J VanLeuven, John Branson Byers, Hannah C Schriever, Rebecca E Ball, Jessica M Carpenter, Chelsea E Gunderson, Nikolay M Filipov, Ping Ma, Peter A Kner, James D Lauderdal. Decreased GABA levels during development result in increased connectivity in the larval zebrafish tectum. bioRxiv : the preprint server for biology. 2024-09-24. PMID:39314470. |
later in cns development, gabaergic signaling acts in an inhibitory manner when it becomes the predominant inhibitory neurotransmitter in the brain. |
2024-09-24 |
2024-09-26 |
human |
| Megan E Barra, Ken Solt, Xin Yu, Brian L Edlo. Restoring consciousness with pharmacologic therapy: Mechanisms, targets, and future directions. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2024-07-17. PMID:39019729. |
however, the relative contributions of monoaminergic, glutamatergic, cholinergic, gabaergic, and orexinergic neurotransmitter systems to recovery of consciousness after severe brain injury are unknown, and personalized approaches to targeted therapy have yet to be developed. |
2024-07-17 |
2024-07-20 |
Not clear |
| Hiroyuki Ichijo, Nguyen Thi Van Trang, Tomoya Nakamur. Topographic Organization of Glutamatergic and GABAergic Parvalbumin Positive Neurons in the Lateral Habenula. eNeuro. 2024-07-03. PMID:38960707. |
to achieve this, we investigated the proportions of the transmitter machinery in lhb pv neurons, including gabaergic, glutamatergic, serotonergic, cholinergic, and dopaminergic neurotransmitter markers, using transcriptome analysis, mrna in situ hybridization chain reaction, and immunohistochemistry. |
2024-07-03 |
2024-07-10 |
mouse |
| Mie Gangi, Takuma Maruyama, Toshiyuki Ishii, Makoto Kaned. ON and OFF starburst amacrine cells are controlled by distinct cholinergic pathways. The Journal of general physiology. vol 156. issue 8. 2024-06-05. PMID:38836782. |
neither tetrodotoxin, which blocked action potentials, nor ly354740, which blocked neurotransmitter release from sacs, eliminated ach-induced gabaergic feedback in sacs. |
2024-06-05 |
2024-06-07 |
mouse |
| Seong-Eun Lee, Gum Hwa Le. Effects of psoralidin on the expression of glutamate decarboxylases and inhibitory synapse development. Journal of Asian natural products research. 2024-05-16. PMID:38753588. |
gamma-aminobutyric acid (gaba), a major inhibitory neurotransmitter required for excitation/inhibition balance is synthesized by the glutamic acid decarboxylases (gads) in gabaergic neurons. |
2024-05-16 |
2024-05-27 |
Not clear |
| Peeraporn Varinthra, Shameemun Naseer Mohamed Nizarul Anwar, Shu-Ching Shih, Ingrid Y Li. The role of the GABAergic system on insomnia. Tzu chi medical journal. vol 36. issue 2. 2024-04-22. PMID:38645778. |
the gabaergic system is the primary inhibitory neurotransmitter system in the central nervous system. |
2024-04-22 |
2024-04-24 |
Not clear |
| Shubhrat Maheshwari, Aditya Sing. Navigating the Dementia Landscape: Biomarkers and Emerging Therapies. Ageing research reviews. 2024-01-12. PMID:38215913. |
tms has uncovered unique neurophysiological signatures, highlighting impaired plasticity, hyperexcitability, and altered connectivity in ad, while ftd displays differences in neurotransmitter systems, particularly gabaergic and glutamatergic circuits. |
2024-01-12 |
2024-01-15 |
Not clear |
| Aynura Aghayeva, Duygu Gok Yurtseven, Nursel Hasanoglu Akbulut, Ozhan Eyigo. Immunohistochemical determination of the excitatory and inhibitory axonal endings contacting NUCB2/nesfatin-1 neurons. Neuropeptides. vol 103. 2023-12-29. PMID:38157780. |
when the axonal contact of vesicular neurotransmitter transporter proteins was compared between the neurotransmitters, it was determined that the most prominent innervation is gabaergic. |
2023-12-29 |
2024-01-05 |
human |
| Nina-Francesca Parrella, Aron T Hill, Lillian M Dipnall, Yuk Jing Loke, Peter G Enticott, Talitha C For. Inhibitory dysfunction and social processing difficulties in autism: A comprehensive narrative review. Journal of psychiatric research. vol 169. 2023-11-28. PMID:38016393. |
the primary inhibitory neurotransmitter γ-aminobutyric acid (gaba) has a prominent role in regulating neural development and function, with disruption to gabaergic signalling linked to behavioural phenotypes associated with neurodevelopmental disorders, particularly autism. |
2023-11-28 |
2023-12-07 |
Not clear |
| Diego Ruiz-Sobremazas, Mario Ruiz Coca, Miguel Morales-Navas, Rocío Rodulfo-Cárdenas, Caridad López-Granero, Maria Teresa Colomina, Cristian Perez-Fernandez, Fernando Sanchez-Sante. Neurodevelopmental consequences of gestational exposure to particulate matter 10: Ultrasonic vocalizations and gene expression analysis using a bayesian approach. Environmental research. 2023-11-02. PMID:37918762. |
in addition, we were able to detect abnormalities in the expression of genes related to different neurotransmitter systems, such as the gabaergic and monoaminergic systems. |
2023-11-02 |
2023-11-08 |
rat |
| Daphne E Boucherie, Liesbeth Reneman, Henricus G Ruhé, Anouk Schrante. Neurometabolite changes in response to antidepressant medication: A systematic review of NeuroImage. Clinical. vol 40. 2023-10-09. PMID:37812859. |
these different types of medication may involve common neural pathways related to glutamatergic and gabaergic neurotransmitter systems, both of which have been implicated in mdd pathology. |
2023-10-09 |
2023-10-15 |
Not clear |
| Dipanjan Karati, Swarupananda Mukherjee, Souvik Ro. A Promising Drug Candidate as Potent Therapeutic Approach for Neuroinflammation and Its In Silico Justification of Chalcone Congeners: a Comprehensive Review. Molecular neurobiology. 2023-10-06. PMID:37801205. |
these reactions also significantly impact numerous brain functions such as gabaergic signaling and neurotransmitter synthesis through inflammatory cytokines and chemokines. chalcones (1,3-diaryl-2-propen-1-ones) and their heterocyclic counterparts are flavonoids with various biological characteristics including anti-inflammatory activity. |
2023-10-06 |
2023-10-07 |
Not clear |
| Joseph V Martin, Pradip K Sarka. Nongenomic roles of thyroid hormones and their derivatives in adult brain: are these compounds putative neurotransmitters? Frontiers in endocrinology. vol 14. 2023-09-13. PMID:37701902. |
furthermore, thyronines bind specifically to other defined neurotransmitter receptors, including gabaergic, catecholaminergic, glutamatergic, serotonergic and cholinergic systems. |
2023-09-13 |
2023-10-07 |
Not clear |
| Emilio Perucca, H Steve White, Meir Biale. New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development. CNS drugs. 2023-08-21. PMID:37603261. |
the inhibitory neurotransmitter γ-aminobutyric acid (gaba) plays an important role in the modulation of neuronal excitability, and a disruption of gabaergic transmission contributes to the pathogenesis of some seizure disorders. |
2023-08-21 |
2023-09-07 |
Not clear |
| Donald Ielpo, Serafina M Guzzo, Giovanni F Porcheddu, Maria Teresa Viscomi, Clarissa Catale, Ingrid Reverte, Simona Cabib, Carlo Cifani, Gabriella Antonucci, Rossella Ventura, Luisa Lo Iacono, Cristina Marchetti, Diego Andolin. GABAergic miR-34a regulates Dorsal Raphè inhibitory transmission in response to aversive, but not rewarding, stimuli. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 32. 2023-07-31. PMID:37523544. |
these data support a role of mir-34a in regulating gabaergic neurotransmitter activity and behavior in a context-dependent manner and suggest that micrornas could represent a functional signature of specific neuronal subpopulations with valence-specific activity in the brain. |
2023-07-31 |
2023-08-14 |
Not clear |
| Anne Louise Stewart, Jennifer L Payn. Perinatal Depression: A Review and an Update. The Psychiatric clinics of North America. vol 46. issue 3. 2023-07-27. PMID:37500243. |
other, nonpharmacological treatments will be discussed as well as new treatments, including a new class of medications that act on the inhibitory gabaergic neurotransmitter system. |
2023-07-27 |
2023-08-14 |
Not clear |
| Wuhyun Koh, Hankyul Kwak, Eunji Cheong, C Justin Le. GABA tone regulation and its cognitive functions in the brain. Nature reviews. Neuroscience. 2023-07-26. PMID:37495761. |
γ-aminobutyric acid (gaba) is the major inhibitory neurotransmitter released at gabaergic synapses, mediating fast-acting phasic inhibition. |
2023-07-26 |
2023-08-14 |
Not clear |
| Arantzazu Belloso-Iguerategui, Marta Zamarbide, Leyre Merino-Galan, Tatiana Rodríguez-Chinchilla, Belén Gago, Enrique Santamaria, Joaquín Fernández-Irigoyen, Carl W Cotman, G Aleph Prieto, Ana Quiroga-Varela, María Cruz Rodríguez-Oro. Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit. Brain : a journal of neurology. 2023-07-04. PMID:37403195. |
our results not only point to dopaminergic but also to glutamatergic and gabaergic dysfunction, highlighting the relevance of the three neurotransmitter systems in the ventral tegmental area-hippocampus interaction from the earliest stages of parkinsonism. |
2023-07-04 |
2023-08-14 |
human |
| Mallikarjuna Nimgampalle, Harshini Chakravarthy, Sapana Sharma, Shruti Shree, Anoop Ramachandra Bhat, Jangampalli Adi Pradeepkiran, Vasudharani Devanatha. Neurotransmitter Systems in the Etiology of Major Neurological Disorders: Emerging Insights and Therapeutic Implications. Ageing research reviews. 2023-06-29. PMID:37385351. |
neurotransmitter systems are classified as cholinergic, glutamatergic, gabaergic, dopaminergic, serotonergic, histaminergic, or aminergic systems, depending on the type of neurotransmitter secreted by the neuron, allowing effector organs to carry out specific functions by sending nerve impulses. |
2023-06-29 |
2023-08-14 |
Not clear |
| Meng Zhang, Li-Yuan Liu, Yong Xu, Wen-Zhi Wang, Nian-Zhuang Qiu, Fang-Fang Zhang, Feng Zhang, Xiao-Dan Wang, Wei Chen, Xiao-Yan Xu, Yong-Feng Gao, Mei-Hua Chen, Yu-Qin Li, Han-Ting Zhang, Hao Wan. Imbalance of multiple neurotransmitter pathways leading to depression-like behavior and cognitive dysfunction in the triple transgenic mouse model of Alzheimer disease. Metabolic brain disease. 2023-05-31. PMID:37256468. |
the complex and diverse mechanism appears not only relevant to the imbalance of multiple neurotransmitter pathways, including the transmitters and receptors of the monoaminergic, gabaergic, histaminergic, and cholinergic systems, but also related to the changes in l-arginine and creb signaling molecules. |
2023-05-31 |
2023-08-14 |
mouse |